Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: polysorbate 80; ethanol; benzyl alcohol; macrogol 300; citric acid - small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia; hodgkin's disease non-hodgkin's lymphoma.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide

Ireland - English - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - etoposide - concentrate for soln for inf - 20 mg/ml - podophyllotoxin derivatives - it is indicated in adults for the management of: resistant non-seminomatous testicular tumours in combination with other chemotherapeutic agents; small cell lung cancer, in combination with other chemotherapeutic agents; acute monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard induction therapy has failed (in combination with other chemotherapeutic agents).

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide injection, usp is indicated in the management of the following neoplasms: etoposide injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - etoposide 20 mg/ml - solution for injection - 20 mg/ml - active: etoposide 20 mg/ml excipient: benzyl alcohol citric acid ethanol macrogol 300 polysorbate 80 - small-cell lung cancer: etoposide solution for injection is indicated for the first-line treatment of small cell lung cancer with additional chemotherapeutic agents.

Malta - English - Medicines Authority

accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents